Sequana Medical (BRU: SEQUA)

Last close As at 20/11/2024

2.95

0.14 (4.98%)

Market capitalisation

83m

Latest Insights

View More

Healthcare | edison tv

Sequana Medical – executive interview

Healthcare | Flash note

Sequana Medical — New CPT III codes to support reimbursement

Healthcare | Flash note

Sequana Medical — PMA application submitted to FDA for alfapump

Healthcare | Flash note

Sequana Medical — Positive data in non-randomised MOJAVE cohort

Close up of Doctor is showing medical analytics data of Coronavirus (Covid-19), Medical technology concept

Sector

Healthcare

Balance Sheet

Forecast net debt (€m)

15.1

Forecast gearing ratio (%)

80

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (20.7) 5.4 (46.9)
Relative (18.8) (1.7) (43.0)
52 week high/low €6.2/€2.3

Financials

Edison Investment Research is terminating coverage on Sequana Medical (SEQUA). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Y/E Dec Revenue (€m) EBITDA (€m) PBT (€m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 0.4 (23.4) (24.4) (136.37) N/A N/A
2022A 0.9 (28.3) (30.9) (137.33) N/A N/A
2023E 0.7 (29.9) (31.8) (113.66) N/A N/A
2024E 1.8 (29.7) (33.1) (117.06) N/A N/A